Table 1.
Clinical profiles of 173 T2DM patients
| Clinical variables | |
|---|---|
| N (men/women) | 173 (98/75) |
| Age (year) | 62.3 ± 12.2 |
| Duration of T2DM (year) | 13.0 (5.5–20.5) |
| BMI (kg/m2) | 26.1 ± 5.5 |
| Cr (mg/dL) | 0.84 (0.64–1.04) |
| eGFR (mL/min/1.73 m2 | 64.2 ± 25.2 |
| FPG (mg/dL) | 116 ± 35 |
| HbA1c (%) | 8.9 ± 1.5 |
| HOMA-R | 2.00 (1.04–2.96) |
| Ca (mg/dL) | 9.3 ± 0.5 |
| Phosphate (mg/dL) | 3.9 (3.5–4.3) |
| Whole PTH (pg/mL) | 19.2 (18.6–19.8) |
| 1,25(OH)2D (pg/mL) | 40.0 (28.0–52.0) |
| TRACP-5b (mU/dL) | 343 (231–455) |
| BAP (μg/L) | 12.7 (9.1–16.3) |
| Intact OC (ng/mL) | 3.1 (1.8–4.4) |
| TrBMD (mg/cm3) | 172 ± 54 |
| EMTb (Gpa) | 2.96 (2.68–3.24) |
| CoTh (mm) | 3.69 ± 1.28 |
| VF, n (%) | 39 (22.5) |
Data are expressed as n, n (%), mean ± SD, or median (interquartile range)
BMI body mass index, eGFR estimated glomerular filtration rate, FPG Fasting plasma glucose, HOMA-R homeostasis model assessment ratio (insulin resistance), IQR interquartile range